0000950123-20-002404.txt : 20200214 0000950123-20-002404.hdr.sgml : 20200214 20200214150336 ACCESSION NUMBER: 0000950123-20-002404 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20191231 FILED AS OF DATE: 20200214 DATE AS OF CHANGE: 20200214 EFFECTIVENESS DATE: 20200214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MPM Oncology Impact Management LP CENTRAL INDEX KEY: 0001687078 IRS NUMBER: 364818254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-20107 FILM NUMBER: 20618466 BUSINESS ADDRESS: STREET 1: 450 KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 6174259200 MAIL ADDRESS: STREET 1: 450 KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001687078 XXXXXXXX 12-31-2019 12-31-2019 MPM ONCOLOGY IMPACT MANAGEMENT LP

450 KENDALL STREET CAMBRIDGE MA 02142

13F HOLDINGS REPORT 028-20107 N Ansbert Gadicke (617) 425-9200 /s/Ansbert Gadicke Cambridge MA 02-12-2020 0 12 282171 false INFORMATION TABLE 2 form13fInfoTable.xml INFORMATION TABLE FOR FORM 13F argenx SE Common 04016X101 11509 71700 SH SOLE 71700 0 0 ArQule, Inc. Common 04269E107 21840 1094210 SH SOLE 1094210 0 0 Autolus Therapeutics Limited Common 05280R100 525 39740 SH SOLE 39740 0 0 CytomX Therapeutics, Inc. Common 23284F105 7109 855437 SH SOLE 855437 0 0 Deciphera Pharmaceuticals, Inc. Common 24344T101 13417 215570 SH SOLE 215570 0 0 Epizyme, Inc. Common 29428V104 57356 2331534 SH SOLE 2331534 0 0 G1 Therapeutics, Inc. Common 3621LQ109 37631 1423794 SH SOLE 1423794 0 0 Harpoon Therapeutics, Inc. Common 41358P106 57658 3898422 SH SOLE 3898422 0 0 MEI Pharma, Inc. Common 552798202 15500 6250000 SH SOLE 6250000 0 0 Sunesis Pharmaceuticals, Inc. Common 867328700 949 2809912 SH SOLE 2809912 0 0 TCR2 Therapeutics, Inc. Common 87808K106 48138 3370982 SH SOLE 3370982 0 0 YmAbs Therapeutics, Inc. Common 984241109 10540 337291 SH SOLE 337291 0 0